Indications

FeRivaFA^® is an iron supplement indicated for use in improving the nutritional status of patients with iron deficiency.

Contraindication

Hemochromatosis and hemosiderosis are contraindicated to iron therapy. 

Important Safety Information

FeRivaFA^® has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range. Talk to your doctor or healthcare practitioner before taking FeRivaFA^®, especially if you have a known sensitivity to any of its ingredients and tell your doctor or healthcare practitioner about any medications you are taking, including antacids and antibiotics. Do not take this product if you have ever been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis. Do not exceed the prescribed dosing regimen of FeRivaFA^® and take FeRivaFA^® precisely as recommended by your physician or healthcare practitioner. 

WARNINGS

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Allergic sensitization has been reported following both oral and parenteral administration of folic acid. To report negative side effects, we encourage you to contact Avion Pharmaceuticals at 1-888-61-AVION or to report these side effects to the FDA, 1-800-FDA-1088 or www.fda.gov/medwatch. 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.